Condensed Statements of Operations (Unaudited, Restated) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenue:
Product Sales	$ 646,147	$ 647,315
Royalties	348,744	514,197
Licensing Revenue	262,689	562,689
Development Fees and Other	165,628	238,974
Tarsa Revenue	328,075	162,634
Total Revenue	1,751,283	2,125,809
Operating Expenses:
Research and Development	1,258,659	2,421,128
Cost of Goods Sold	246,357	264,898
General and Administrative	2,093,172	1,973,678
Unallocated Facility Expenses	859,113	750,057
Severance and Other Related Expenses		349,980
Total Operating Expenses	4,457,301	5,759,741
Operating Loss	(2,706,018)	(3,633,932)
Other Income (Expense):
Gain (Loss) on Change in Fair Value of Embedded Conversion Feature	2,920,000	(26,440,000)
Interest and Other Income	80,433	27,695
Interest Expense	(2,867,002)	(2,438,540)
Loss from Investment in Tarsa	(650,571)
Loss from Investment in former China Joint Venture		(302,855)
Loss Before Income Taxes	(3,223,158)	(32,787,632)
Income Tax Benefit, primarily from refund of federal tax credits	26,757
Net Loss	$ (3,196,401)	$ (32,787,632)
Loss Per Share – Basic and Diluted:
Net Loss Per Share (in Dollars per share)	$ (0.03)	$ (0.35)
Weighted Average Number of Shares Outstanding – Basic and Diluted (in Shares)	95,314,825	92,460,582